New research has uncovered why some cancers are far more dangerous than others, with findings that could enhance diagnosis and treatment. The study reveals that cancers originating from smaller cells packed densely with genetic material tend to lead to worse illnesses and poorer outcomes.
Understanding Cancer Cell Replication
Cancer is primarily caused by errors in cell replication that alter the number of chromosomes. Most body cells are diploid, containing two copies of each chromosome—one from each parent. However, replication errors can produce an abnormal number of chromosomes, a hallmark of cancer. Some cells may end up with four full sets of chromosomes, a condition known as tetraploidy.
Researchers from Virginia Tech in the US found that smaller cells with tetraploidy cause larger cancerous tumours and poorer prognosis in mice. "The presence of even a small fraction of these tetraploid cells can promote the recruitment of extra non-cancerous cells that support further tumour progression," said Megan Sweet, lead author of the study published in Cancer Research.
Key Findings on Cell Size and Tumour Growth
The team observed that smaller tetraploid human cells grown in a lab—about 25-30 per cent smaller than normal—were more likely to produce tumours than larger ones. This pattern held true in mice models, even for breast and bowel cancer. "We already knew that tetraploidy can make cells more tumorigenic, but now we know that incorporating cell size can be more predictive of tumorigenic potential," explained cell biologist Daniela Cimini.
In a related study published in PNAS, researcher Mat Bloomfield noted, "The smaller clones are more aggressive. They grow faster, are more invasive, and more tolerant of common anti-cancer and stress-inducing drugs." This suggests that the size of a cell and its nucleus—where genetic material is housed—may be a crucial indicator of tumour-generating potential.
Implications for Future Research
Scientists hope to further understand the mechanisms behind these findings. They suspect that the compact nature of small cells makes cellular processes like nutrient uptake, gene expression, and protein interactions more efficient. The findings could "reveal new genetic targets and size-specific dependencies" that may improve diagnosis and treatment, according to the researchers.
These insights offer a promising avenue for developing more effective cancer therapies tailored to the size and genetic characteristics of cancer cells.
